Lappuse 1 no 32 rezultātiem
This invention relates to novel aryl oxime-carbamates and carbonates having bronchodilatory and anti-inflammatory activities and being useful in the treatment of asthma.
Asthma is a disease in which respiratory distress is produced as a result of airway narrowing. This narrowing is caused largely by
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to novel corticoid derivatives. Corticoid derivatives have anti anti-inflammatory activity and are useful as pharmaceuticals.
2. Description of the Prior Art
6-oxo corticoids are disclosed in Japanese Unexamined Patent
BACKGROUND OF THE INVENTION
This invention pertains to a new method for treating pain, inflammation, trauma, allergy, and disease by the topical application of a therapeutic agent having previously unrecognized analgesic, anti-allergenic, and anti-inflammatory properties, or by the topical
BACKGROUND OF THE INVENTION
The present invention concerns novel ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory substance having a carboxylic acid function, process for their preparation and pharmaceutical compositions containing them.
The novel esters according to the invention
FIELD OF THE INVENTION
The present invention relates to pharmaceutical composition which contains active ingredients and is effective as a self-sustaining delivery mechanism for its own delivery for desired extended periods of time. More particularly, this invention relates to an injectable
FIELD OF THE INVENTION
This invention relates generally to compositions and methods useful in the prevention and treatment of osteoporosis and for bone and fracture repair. More specifically, the invention relates to slow-releasing calcium phosphate-based materials incorporating Mg, Zn, F, carbonate
FIELD OF THE INVENTION
The invention relates to antiasthmatic carbonate and carbamate derivatives of glucocorticoids.
BACKGROUND OF THE INVENTION
Glucocorticoids, in topical, oral and inhaled formulations, are useful for their anti-inflammatory and immunosuppressive activities. Notwithstanding the
CROSS REFERENCES TO RELATED APPLICATIONS
This application claims priority to European Patent Application No. 08162066.8 filed on Aug. 8, 2008, which is incorporated herein by reference in its entirety.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to quinuclidine carbonate salts which act as muscarinic receptor antagonists. The present invention also relates to methods of preparing such a salt, compositions which contain such a salt, and methods of treating
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to quinuclidine carbonate salts which act as muscarinic receptor antagonists. The present invention also relates to methods of preparing such a salt, compositions which contain such a salt, and methods of treating
FIELD OF THE INVENTION
The invention relates to methods of treating rhinitis, asthma, and inflammation using carbonate and carbamate derivatives of glucocorticoids in combination with .beta..sub.2 adrenergic agonists.
BACKGROUND OF THE INVENTION
Glucocorticoids, in topical, oral and inhaled
It is an object of the present invention to provide novel steroid-21-halogeno-17-(alkyl carbonates) of the formula I ##STR1## in which A denotes the groupings ##STR2## Y denotes hydrogen, fluorine or a chlorine atom, Z denotes hydrogen, chlorine, fluorine or a methyl group,
R.sub.1 denotes fluorine,
FIELD OF THE INVENTION
The invention relates to methods of treating rhinitis, asthma, and inflammation using carbonate and carbamate derivatives of glucocorticoids in combination with .beta..sub.2 adrenergic agonists.
BACKGROUND OF THE INVENTION
Glucocorticoids, in topical, oral and inhaled
FIELD OF THE INVENTION
The invention relates to methods of treating rhinitis, asthma, and inflammation using carbonate and carbamate derivatives of glucocorticoids in combination with .beta..sub.2 adrenergic agonists.
BACKGROUND OF THE INVENTION
Glucocorticoids, in topical, oral and inhaled
FIELD OF THE INVENTION
The invention relates to methods of treating rhinitis, asthma, and inflammation using carbonate and carbamate derivatives of glucocorticoids in combination with .beta..sub.2 adrenergic agonists.
BACKGROUND OF THE INVENTION
Glucocorticoids, in topical, oral and inhaled